RT Journal Article
SR Electronic
A1 Rizzo, Toni
T1 LH and Testosterone Significantly Reduced With NKB Receptor Antagonist in PCOS
JF MD Conference Express
YR 2015
FD SAGE Publications
VO 15
IS 4
SP 16
OP 17
DO 10.1177/1559897715581820
UL http://mdc.sagepub.com/content/15/4/16.1.abstract
AB Luteinizing hormone and testosterone levels were significantly decreased by treatment with the neurokinin B receptor antagonist AZD4901 80 mg compared with placebo in women with polycystic ovary syndrome. The reductions were maintained throughout the 28 days of treatment. AZD4901 was safe and well tolerated in this group of patients.